Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid (RAD) is likely to have gained from strength in PBM, RxEvolution strategy and delivery services in Q4. Rising wage costs and higher payroll expenses are likely to have been concerns.

Factors Likely to Decide Rite Aid's (RAD) Fate in Q4 Earnings

Rite Aid (RAD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Rite Aid (RAD) Stock Jumps 7.4%: Will It Continue to Soar?

Rite Aid Corp (NYSE: RAD) is down 25% in the stock market on Thursday after a Deutsche Bank analyst said the drugstore chain might fail to continue as an “operating company”. George Hill has $1.0 a share price target George Hill downgraded the stock this morning to “sell” with a price target of $1.0 a […] The post Rite Aid might fail to ‘continue as an operating company' appeared first on Invezz.

Rite Aid might fail to ‘continue as an operating company'

Beyond Meat

Beyond Meat Inc. BYND, -1.19% announced Thursday that Beyond Meatballs and the Beyond Burger product will be available at about 2,000 Rite Aid Corp. RAD, -21.39% locations around the country. The pharmacy retailer is the latest addition to a long list of restaurant chains and retailers that carry the plant-based meat company's products.

Beyond Meat to begin selling at 2,000 Rite Aid locations

Rite Aid shares plunged on Thursday after Deutsche Bank downgraded the pharmacy retail chain and cut the stock's price target ahead of the release of its quarterly results next week.

Rite Aid shares tank on Deutsche Bank downgrade

Deutsche Bank said Rite Aid's upcoming 2023 guidance for annual adjusted EBITDA may be unattainable.

Rite Aid plummets 25% after Deutsche Bank slashes price target to $1 as COVID-19 'hastens the decline' of the company's retail pharmacy business

An analyst gave a bleak outlook for the pharmacy stock.

Why Rite Aid Stock Is Crashing Today

A Wall Street downgrade has Rite Aid plunging into the red. Here's what investors need to know about the future of RAD stock.

Why One Analyst Thinks Rite Aid (RAD) Stock Is Headed to $1

Rite Aid Corporation (NYSE:RAD) stock is crumbling today, down 17.9% to trade at $6.93, after a downgrade from Deutsche Bank to "sell" from "hold," with a price-target cut to $1 from $16.

Rite Aid Stock Rattled After Analyst Cuts Price Target to $1

Ahead of the Company's fiscal Q4 results on April 14, Deutsche Bank downgraded Rite Aid Corporation (NYSE: RAD) to Sell from Hold with a price target of $1, down from $16. Analyst George Hill believes COVID has "hastened the decline" for the Company, and he sees the.

Deutsche Bank Sees Potential 'Dramatic Negative Inflection Point' For Rite Aid

Rite Aid Corp (NYSE: RAD) shares are trading significantly lower Thursday after Deutsche Bank analyst George Hill downgraded the stock from a Hold rating to a Sell rating and lowered the price target from $16 to $1. According to reports, Hill believes Rite Aid is in decline and.

Why Rite Aid Shares Are Falling Today

Deutsche Bank downgrades the stock to a Sell and sets a price target of $1, a Wall Street low.

Rite Aid Stock Plummets. Why This Analyst Believes the Shares Could Fall to $1.

Shares of Rite Aid Corp. plunged toward a 2 1/2-year low Thursday, after Deutsche Bank analyst George Hill issued a dire warning that the drugstore chain's equity could be worthless.

The Ratings Game: Rite Aid stock plunges after Deutsche Bank cuts target to $1, warns of a ‘dramatic negative inflection point'

Medicare Part B will cover up to eight over-the-counter COVID-19 tests each month PHILADELPHIA, April 4, 2022 /PRNewswire/ -- Beginning today, people with Medicare Part B can visit any Rite Aid (NYSE: RAD) location and receive up to eight over-the-counter COVID-19 tests every month at no cost. As part of the Medicare COVID-19 Over-the-Counter Test Initiative, people covered by Medicare Part B can bring their red, white, and blue Medicare card to any Rite Aid location to receive their no cost tests.

Rite Aid Offers Free COVID-19 Tests to Medicare Beneficiaries

Appointments can be made online and walk-in appointments available PHILADELPHIA , March 30, 2022 /PRNewswire/ -- Rite Aid (NYSE: RAD) today announced it will begin administering a second booster of the mRNA Pfizer and Moderna COVID-19 vaccines for eligible individuals, following approval by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Individuals aged 50 and older and certain immunocompromised individuals aged 12 and older may receive a second booster at least four months after their first booster.

Second COVID-19 Boosters Now Available at All Rite Aid Locations for Eligible Individuals

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2022 Fourth Quarter, which ended February 26, 2022, on Thursday, April 14, 2022. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. Eastern Time on Thursday, April 14, 20

Rite Aid to Release Fourth Quarter Results on April 14

Rite Aid eliminated its chief operating officer position and consolidated pharmacy roles to “streamline operations.”

Rite Aid Shakes Up Management, Eliminates COO Position

Shares of Rite Aid Corp. RAD, -1.42% were indicated up nearly 1% in premarket trading Tuesday, after the drug store chain announced a realignment of its management team that includes the elimination of the chief operating officer (COO) position and consolidation of leadership of its pharmacy business. As part of the realignment, COO Jim Peters and Chief Pharmacy Officer Jocelyn Konrad have left the company, after both were in their roles since October 2019.

Rite Aid eliminates COO position as part of management realignment

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation Realigns Management to Streamline Operations

Rite Aid Corporation Realigns Management to Streamline Operations

GlaxoSmithKline

Merck

Vir Biotechnology

Walgreens

CVS Health

Kroger

President Joe Biden announced during his State of the Union address on Tuesday that individuals who test positive for Covid-19 at a pharmacy will soon be able to get free antiviral treatments immediately after. The cost will be funded by the federal government, which could result in a huge boost to the revenue of companies in the pharmaceutical, pharmacy and diagnostic industries over the coming year.

Health Care Stocks to Watch as Test to Treat Plan Looks to Prevent Lockdowns

CAMP HILL, Pa.--(BUSINESS WIRE)--Underscoring its new identity, Rite Aid Healthy Futures is announcing a $10 million, six-city initiative supporting healthy, equitable neighborhoods

Rite Aid Healthy Futures Launches Its Next Era of Philanthropy

Pharmacy chains may be shuttering locations, but that's not necessarily a reason to panic.

Is the Pharmacy Dying?

Babylon Holdings Ltd

SEATTLE, Feb. 17, 2022 /PRNewswire/ -- Today, Bartell Drugs (Bartell's), a wholly-owned subsidiary of Rite Aid Corporation (NYSE: RAD), and Higi, a wholly-owned subsidiary of Babylon (NYSE: BBLN), announced the roll out of enhanced health self-screening stations, now available at 50 Bartell's stores throughout the Puget Sound region. The partnership with Higi, a consumer health engagement company that provides a connected network of Smart Health Stations and digital health engagement tools, allows customers a free option to check their risk for hypertension, obesity, type 2 diabetes, heart attack and stroke.

BARTELL DRUGS EXPANDS HEALTH SELF-SCREENING OPTIONS WITH LAUNCH OF NEW HIGI SMART HEALTH STATIONS

Despite cost headwinds, strength in online services and the PBM market will likely aid Rite Aid (RAD) in the times ahead.

Rite Aid (RAD) Dips 21.6% in Three Months: Can It Bounce Back?

A spate of high-profile robberies at New York City Rite Aid locations has highlighted store closures in the area, but the pharmacy and retail giant is pushing back against the notion that its workers are being left without jobs – or that its shops are shuttering only as a result of organized retail theft.

News for Rite Aid Stock (RAD)